{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:24:55Z","timestamp":1781141095443,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"S15","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61772552"],"award-info":[{"award-number":["61772552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A drug-drug interaction (DDI) is defined as a drug effect modified by another drug, which is very common in treating complex diseases such as cancer. Many studies have evidenced that some DDIs could be an increase or a decrease of the drug effect. However, the adverse DDIs maybe result in severe morbidity and even morality of patients, which also cause some drugs to withdraw from the market. As the multi-drug treatment becomes more and more common, identifying the potential DDIs has become the key issue in drug development and disease treatment. However, traditional biological experimental methods, including in vitro and vivo, are very time-consuming and expensive to validate new DDIs. With the development of high-throughput sequencing technology, many pharmaceutical studies and various bioinformatics data provide unprecedented opportunities to study DDIs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>In this study, we propose a method to predict new DDIs, namely DDIGIP, which is based on Gaussian Interaction Profile (GIP) kernel on the drug-drug interaction profiles and the Regularized Least Squares (RLS) classifier. In addition, we also use the k-nearest neighbors (KNN) to calculate the initial relational score in the presence of new drugs via the chemical, biological, phenotypic data of drugs. We compare the prediction performance of DDIGIP with other competing methods via the 5-fold cross validation, 10-cross validation and de novo drug validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conlusion<\/jats:title><jats:p>In 5-fold cross validation and 10-cross validation, DDRGIP method achieves the area under the ROC curve (AUC) of 0.9600 and 0.9636 which are better than state-of-the-art method (L1 Classifier ensemble method) of 0.9570 and 0.9599. Furthermore, for new drugs, the AUC value of DDIGIP in de novo drug validation reaches 0.9262 which also outperforms the other state-of-the-art method (Weighted average ensemble method) of 0.9073. Case studies and these results demonstrate that DDRGIP is an effective method to predict DDIs while being beneficial to drug development and disease treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-019-3093-x","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T09:02:35Z","timestamp":1577178155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels"],"prefix":"10.1186","volume":"20","author":[{"given":"Cheng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"3093_CR1","first-page":"1972","volume":"43","author":"NR Crowther","year":"1997","unstructured":"Crowther NR, Holbrook AM, Kenwright R, Kenwright M. Drug interactions among commonly used medications. chart simplifies data from critical literature review. Can Fam Phys. 1997; 43:1972.","journal-title":"Can Fam Phys"},{"issue":"5","key":"3093_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/1389200033489361","volume":"4","author":"K Venkatakrishnan","year":"2003","unstructured":"Venkatakrishnan K, von Moltke LL, Obach R, Greenblatt DJ. Drug metabolism and drug interactions: application and clinical value of in vitro models. Curr Drug Metabolism. 2003; 4(5):423\u201359.","journal-title":"Curr Drug Metabolism"},{"issue":"6","key":"3093_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2165\/00002018-199512060-00005","volume":"12","author":"D Quinn","year":"1995","unstructured":"Quinn D, Day R. Drug interactions of clinical importance. Drug Safety. 1995; 12(6):393\u2013452.","journal-title":"Drug Safety"},{"issue":"1","key":"3093_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12916-016-0735-y","volume":"14","author":"IJ Onakpoya","year":"2016","unstructured":"Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review. BMC Med. 2016; 14(1):191.","journal-title":"BMC Med"},{"key":"3093_CR5","unstructured":"CDC. Health, United States, 2014 (5\/2015)-hus14.pdf. http:\/\/www.cdc.gov\/nchs\/data\/hus\/hus14.pdf. Accessed 15 Nov 2017."},{"issue":"7","key":"3093_CR6","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1158\/0008-5472.CAN-03-3856","volume":"64","author":"R Nahta","year":"2004","unstructured":"Nahta R, Hung M-C, Esteva FJ. The her-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells. Cancer Res. 2004; 64(7):2343\u20136.","journal-title":"Cancer Res"},{"issue":"2","key":"3093_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C. Drug combination studies and their synergy quantification using the chou-talalay method. Cancer Res. 2010; 70(2):440\u20136.","journal-title":"Cancer Res"},{"issue":"suppl_1","key":"3093_CR8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006; 34(suppl_1):668\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"3093_CR9","first-page":"1035","volume":"39","author":"C Knox","year":"2010","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al. Drugbank 3.0: a comprehensive resource for \u2019omics\u2019 research on drugs. Nucleic Acids Res. 2010; 39(suppl_1):1035\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3093_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2013","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, et al. Drugbank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2013; 42(D1):1091\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_2","key":"3093_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. Pubchem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009; 37(suppl_2):623\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3093_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/msb.2009.98","volume":"6","author":"M Kuhn","year":"2010","unstructured":"Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P. A side effect resource to capture phenotypic effects of drugs. Mole Syst Biol. 2010; 6(1):343.","journal-title":"Mole Syst Biol"},{"issue":"125","key":"3093_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Patrick PY, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Trans Med. 2012; 4(125):125\u201331.","journal-title":"Sci Trans Med"},{"issue":"suppl_1","key":"3093_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2009","unstructured":"Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. Kegg for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2009; 38(suppl_1):355\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3093_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/pds.1746","volume":"18","author":"E Poluzzi","year":"2009","unstructured":"Poluzzi E, Raschi E, Moretti U, De Ponti F. Drug-induced torsades de pointes: data mining of the public version of the fda adverse event reporting system (aers). Pharmacoepidemiol Drug Safety. 2009; 18(6):512\u20138.","journal-title":"Pharmacoepidemiol Drug Safety"},{"issue":"6","key":"3093_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","volume":"19","author":"S Vilar","year":"2012","unstructured":"Vilar S, Harpaz R, Uriarte E, Santana L, Rabadan R, Friedman C. Drug-drug interaction through molecular structure similarity analysis. J Am Med Inf Assoc. 2012; 19(6):1066\u201374.","journal-title":"J Am Med Inf Assoc"},{"issue":"2","key":"3093_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/07391102.2016.1138142","volume":"35","author":"L Liu","year":"2017","unstructured":"Liu L, Chen L, Zhang Y. -H., Wei L, Cheng S, Kong X, Zheng M, Huang T, Cai Y-D. Analysis and prediction of drug\u2013drug interaction by minimum redundancy maximum relevance and incremental feature selection. J Biomole Struct Dynamics. 2017; 35(2):312\u201329.","journal-title":"J Biomole Struct Dynamics"},{"issue":"e2","key":"3093_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/amiajnl-2013-002512","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng F, Zhao Z. Machine learning-based prediction of drug\u2013drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J Am Med Inf Assoc. 2014; 21(e2):278\u201386.","journal-title":"J Am Med Inf Assoc"},{"issue":"3","key":"3093_CR19","doi-asserted-by":"publisher","first-page":"58321","DOI":"10.1371\/journal.pone.0058321","volume":"8","author":"S Vilar","year":"2013","unstructured":"Vilar S, Uriarte E, Santana L, Tatonetti NP, Friedman C. Detection of drug-drug interactions by modeling interaction profile fingerprints. PloS one. 2013; 8(3):58321.","journal-title":"PloS one"},{"issue":"1","key":"3093_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13321-017-0200-8","volume":"9","author":"T Takeda","year":"2017","unstructured":"Takeda T, Hao M, Cheng T, Bryant SH, Wang Y. Predicting drug\u2013drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge. J Cheminforma. 2017; 9(1):16.","journal-title":"J Cheminforma"},{"issue":"5","key":"3093_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2174\/138920021505141126102223","volume":"15","author":"S Vilar","year":"2014","unstructured":"Vilar S, Uriarte E, Santana L, Friedman C, P Tatonetti N. State of the art and development of a drug-drug interaction large scale predictor based on 3d pharmacophoric similarity. Curr Drug Metabolism. 2014; 15(5):490\u2013501.","journal-title":"Curr Drug Metabolism"},{"issue":"8","key":"3093_CR22","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1021\/acs.jcim.5b00119","volume":"55","author":"M Herrero-Zazo","year":"2015","unstructured":"Herrero-Zazo M, Segura-Bedmar I, Hastings J, Mart\u00ednez P. Dinto: using owl ontologies and swrl rules to infer drug\u2013drug interactions and their mechanisms. J Chem Inf Modeling. 2015; 55(8):1698\u2013707.","journal-title":"J Chem Inf Modeling"},{"issue":"12","key":"3093_CR23","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/bioinformatics\/btv080","volume":"31","author":"P Li","year":"2015","unstructured":"Li P, Huang C, Fu Y, Wang J, Wu Z, Ru J, Zheng C, Guo Z, Chen X, Zhou W, et al. Large-scale exploration and analysis of drug combinations. Bioinformatics. 2015; 31(12):2007\u201316.","journal-title":"Bioinformatics"},{"key":"3093_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jbi.2017.04.021","volume":"70","author":"R Ferdousi","year":"2017","unstructured":"Ferdousi R, Safdari R, Omidi Y. Computational prediction of drug-drug interactions based on drugs functional similarities. J Biomed Informa. 2017; 70:54\u201364.","journal-title":"J Biomed Informa"},{"issue":"20","key":"3093_CR25","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/bioinformatics\/btw342","volume":"32","author":"D Sridhar","year":"2016","unstructured":"Sridhar D, Fakhraei S, Getoor L. A probabilistic approach for collective similarity-based drug\u2013drug interaction prediction. Bioinformatics. 2016; 32(20):3175\u201382.","journal-title":"Bioinformatics"},{"key":"3093_CR26","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.1038\/srep12339","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang P, Wang F, Hu J, Sorrentino R. Label propagation prediction of drug-drug interactions based on clinical side effects. Sci Rep. 2015; 5:12339.","journal-title":"Sci Rep"},{"issue":"9","key":"3093_CR27","first-page":"498","volume":"4","author":"D-S Cao","year":"2015","unstructured":"Cao D-S, Xiao N, Li Y-J, Zeng W-B, Liang Y-Z, Lu A-P, Xu Q-S, Chen A. Integrating multiple evidence sources to predict adverse drug reactions based on a systems pharmacology model. CPT: Pharmacom Syst Pharmacol. 2015; 4(9):498\u2013506.","journal-title":"CPT: Pharmacom Syst Pharmacol"},{"issue":"7","key":"3093_CR28","doi-asserted-by":"publisher","first-page":"1004975","DOI":"10.1371\/journal.pcbi.1004975","volume":"12","author":"X Chen","year":"2016","unstructured":"Chen X, Ren B, Chen M, Wang Q, Zhang L, Yan G. Nllss: predicting synergistic drug combinations based on semi-supervised learning. PLoS Comput Biol. 2016; 12(7):1004975.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"3093_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12859-016-1415-9","volume":"18","author":"W Zhang","year":"2017","unstructured":"Zhang W, Chen Y, Liu F, Luo F, Tian G, Li X. Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data. BMC bioinformatics. 2017; 18(1):18.","journal-title":"BMC bioinformatics"},{"issue":"3","key":"3093_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.yrtph.2009.11.006","volume":"56","author":"EJ Matthews","year":"2010","unstructured":"Matthews EJ, Frid AA. Prediction of drug-related cardiac adverse effects in humans-a: Creation of a database of effects and identification of factors affecting their occurrence. Reg Toxicol Pharmacol. 2010; 56(3):247\u201375.","journal-title":"Reg Toxicol Pharmacol"},{"issue":"2","key":"3093_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/acs.molpharmaceut.5b00762","volume":"13","author":"AV Zakharov","year":"2016","unstructured":"Zakharov AV, Varlamova EV, Lagunin AA, Dmitriev AV, Muratov EN, Fourches D, Kuz\u2019min VE, Poroikov VV, Tropsha A, Nicklaus MC. Qsar modeling and prediction of drug\u2013drug interactions. Mole Pharma. 2016; 13(2):545\u201356.","journal-title":"Mole Pharma"},{"issue":"4","key":"3093_CR32","doi-asserted-by":"publisher","first-page":"61468","DOI":"10.1371\/journal.pone.0061468","volume":"8","author":"A Cami","year":"2013","unstructured":"Cami A, Manzi S, Arnold A, Reis BY. Pharmacointeraction network models predict unknown drug-drug interactions. PloS one. 2013; 8(4):61468.","journal-title":"PloS one"},{"key":"3093_CR33","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1038\/srep07160","volume":"4","author":"H Huang","year":"2014","unstructured":"Huang H, Zhang P, Qu XA, Sanseau P, Yang L. Systematic prediction of drug combinations based on clinical side-effects. Sci Rep. 2014; 4:7160.","journal-title":"Sci Rep"},{"issue":"18","key":"3093_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/bioinformatics\/btq382","volume":"26","author":"L Tari","year":"2010","unstructured":"Tari L, Anwar S, Liang S, Cai J, Baral C. Discovering drug\u2013drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics. 2010; 26(18):547\u201353.","journal-title":"Bioinformatics"},{"issue":"2","key":"3093_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/amiajnl-2013-001612","volume":"21","author":"SV Iyer","year":"2014","unstructured":"Iyer SV, Harpaz R, LePendu P, Bauer-Mehren A, Shah NH. Mining clinical text for signals of adverse drug-drug interactions. J Am Med Informa Assoc. 2014; 21(2):353\u201362.","journal-title":"J Am Med Informa Assoc"},{"issue":"1","key":"3093_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40264-015-0352-2","volume":"39","author":"JM Banda","year":"2016","unstructured":"Banda JM, Callahan A, Winnenburg R, Strasberg HR, Cami A, Reis BY, Vilar S, Hripcsak G, Dumontier M, Shah NH. Feasibility of prioritizing drug\u2013drug-event associations found in electronic health records. Drug Safety. 2016; 39(1):45\u201357.","journal-title":"Drug Safety"},{"issue":"6","key":"3093_CR37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2174\/1574893611666160618094219","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen L, Chu C, Zhang Y-H, Zheng M, Zhu L, Kong X, Huang T. Identification of drug-drug interactions using chemical interactions. Curr Bioinforma. 2017; 12(6):526\u201334.","journal-title":"Curr Bioinforma"},{"issue":"2","key":"3093_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/1574893611666160125222144","volume":"11","author":"J Wang","year":"2016","unstructured":"Wang J, Kribelbauer J, Rabadan R. Network propagation reveals novel features predicting drug response of cancer cell lines. Curr Bioinforma. 2016; 11(2):203\u201310.","journal-title":"Curr Bioinforma"},{"issue":"5","key":"3093_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1574893613666180118104250","volume":"13","author":"H Liu","year":"2018","unstructured":"Liu H, Luo L, Cheng Z, Sun J, Guan J, Zheng J, Zhou S. Group-sparse modeling drug-kinase networks for predicting combinatorial drug sensitivity in cancer cells. Curr Bioinforma. 2018; 13(5):437\u201343.","journal-title":"Curr Bioinforma"},{"issue":"17","key":"3093_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk H, \u00d6zg\u00fcr A, Ozkirimli E. Deepdta: deep drug\u2013target binding affinity prediction. Bioinformatics. 2018; 34(17):821\u20139.","journal-title":"Bioinformatics"},{"issue":"21","key":"3093_CR41","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/bioinformatics\/btr500","volume":"27","author":"T van Laarhoven","year":"2011","unstructured":"van Laarhoven T, Nabuurs SB, Marchiori E. Gaussian interaction profile kernels for predicting drug\u2013target interaction. Bioinformatics. 2011; 27(21):3036\u201343.","journal-title":"Bioinformatics"},{"issue":"Article ID 2713","key":"3093_CR42","first-page":"10","volume":"2017","author":"C Yan","year":"2017","unstructured":"Yan C, Wang J, Lan W, Wu F-X, Pan Y. Sdtrls: Predicting drug-target interactions for complex diseases based on chemical substructures. Complexity. 2017; 2017(Article ID 2713280):10.","journal-title":"Complexity"},{"issue":"3","key":"3093_CR43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/bioinformatics\/btw639","volume":"33","author":"W Lan","year":"2016","unstructured":"Lan W, Li M, Zhao K, Liu J, Wu F-X, Pan Y, Wang J. Ldap: a web server for lncrna-disease association prediction. Bioinformatics. 2016; 33(3):458\u201360.","journal-title":"Bioinformatics"},{"issue":"1","key":"3093_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1109\/TCBB.2017.2776101","volume":"16","author":"C Yan","year":"2019","unstructured":"Yan C, Wang J, Ni P, Lan W, Wu FX, Pan Y. Dnrlmf-mda:predicting microrna-disease associations based on similarities of micrornas and diseases. IEEE\/ACM Trans Comput Biol Bioinforma. 2019; 16(1):233\u201343.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinforma"},{"key":"3093_CR45","doi-asserted-by":"publisher","unstructured":"Yan C, Duan G, Wu F, Pan Y, Wang J. Brwmda: Predicting microbe-disease associations based on similarities and bi-random walk on disease and microbe networks. IEEE\/ACM Trans Comput Biol Bioinforma. 2019. https:\/\/doi.org\/10.1109\/TCBB.2019.2907626. (to be published).","DOI":"10.1109\/TCBB.2019.2907626"},{"key":"3093_CR46","doi-asserted-by":"publisher","unstructured":"Yan C, Duan G, Wu F, Pan Y, Wang J. Mchmda: Predicting microbe-disease associations based on similarities and low-rank matrix completion. IEEE\/ACM Trans Comput Biol Bioinforma. 2019. https:\/\/doi.org\/10.1109\/TCBB.2019.2926716. (to be published).","DOI":"10.1109\/TCBB.2019.2926716"},{"issue":"3","key":"3093_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nmeth.2810","volume":"11","author":"B Wang","year":"2014","unstructured":"Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, Haibe-Kains B, Goldenberg A. Similarity network fusion for aggregating data types on a genomic scale. Nat Methods. 2014; 11(3):333.","journal-title":"Nat Methods"},{"issue":"2","key":"3093_CR48","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1752-0509-4-S2-S6","volume":"4","author":"Z Xia","year":"2010","unstructured":"Xia Z, Wu L-Y, Zhou X, Wong ST. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. BMC Syst Biol. 2010; 4(2):S6.","journal-title":"BMC Syst Biol"},{"issue":"19","key":"3093_CR49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12859-018-2522-6","volume":"19","author":"C Yan","year":"2018","unstructured":"Yan C, Wang J, Wu F-X. Dwnn-rls: regularized least squares method for predicting circrna-disease associations. BMC bioinformatics. 2018; 19(19):520.","journal-title":"BMC bioinformatics"},{"issue":"2","key":"3093_CR50","first-page":"333","volume":"18","author":"Z Wu","year":"2016","unstructured":"Wu Z, Cheng F, Li J, Li W, Liu G, Tang Y. Sdtnbi: an integrated network and chemoinformatics tool for systematic prediction of drug\u2013target interactions and drug repositioning. Brief Bioinforma. 2016; 18(2):333\u201347.","journal-title":"Brief Bioinforma"},{"issue":"17","key":"3093_CR51","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/bioinformatics\/btw228","volume":"32","author":"H Luo","year":"2016","unstructured":"Luo H, Wang J, Li M, Luo J, Peng X, Wu F-X, Pan Y. Drug repositioning based on comprehensive similarity measures and bi-random walk algorithm. Bioinformatics. 2016; 32(17):2664\u201371.","journal-title":"Bioinformatics"},{"issue":"11","key":"3093_CR52","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/bioinformatics\/bty013","volume":"34","author":"H Luo","year":"2018","unstructured":"Luo H, Li M, Wang S, Liu Q, Li Y, Wang J. Computational drug repositioning using low-rank matrix approximation and randomized algorithms. Bioinformatics. 2018; 34(11):1904\u201312.","journal-title":"Bioinformatics"},{"key":"3093_CR53","doi-asserted-by":"publisher","unstructured":"Luo H, Wang J, Li M, Luo J, Ni P, Zhao K, Wu FX, Pan Y. Computational drug repositioning with random walk on a heterogeneous network. IEEE\/ACM Trans Comput Biol Bioinforma. 2018. https:\/\/doi.org\/10.1109\/TCBB.2018.2832078. (to be published).","DOI":"10.1109\/TCBB.2018.2832078"},{"issue":"19","key":"3093_CR54","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/bioinformatics\/bty327","volume":"34","author":"C Lu","year":"2018","unstructured":"Lu C, Yang M, Luo F, Wu F-X, Li M, Pan Y, Li Y, Wang J. Prediction of lncrna-disease associations based on inductive matrix completion. Bioinformatics. 2018; 34(19):3357\u201364.","journal-title":"Bioinformatics"},{"issue":"6","key":"3093_CR55","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1109\/TCBB.2016.2586190","volume":"15","author":"W Lan","year":"2018","unstructured":"Lan W, Wang J, Li M, Liu J, Wu F-X, Pan Y. Predicting microrna-disease associations based on improved microrna and disease similarities. IEEE\/ACM Trans Comput Biol Bioinforma. 2018; 15(6):1774\u201382.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinforma"},{"issue":"D1","key":"3093_CR56","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2017","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, et al. Drugbank 5.0: a major update to the drugbank database for 2018. Nucleic Acids Res. 2017; 46(D1):1074\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3093_CR57","doi-asserted-by":"crossref","unstructured":"Bhattacharya A, Bandichhor R. Green technologies in the generic pharmaceutical industry. Green Chem Pharma Ind. 2010:304\u20136.","DOI":"10.1002\/9783527629688.ch14"},{"issue":"suppl_2","key":"3093_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/cid\/cit299","volume":"57","author":"S Mauss","year":"2013","unstructured":"Mauss S, Klinker H. Drug-drug interactions in the treatment of hcv among people who inject drugs. Clin Inf diseases. 2013; 57(suppl_2):125\u20138.","journal-title":"Clin Inf diseases"},{"issue":"1","key":"3093_CR59","first-page":"52","volume":"40","author":"LS Welage","year":"2000","unstructured":"Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharma Assoc 1996. 2000; 40(1):52\u201362.","journal-title":"J Am Pharma Assoc 1996"},{"issue":"3","key":"3093_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1388-9842(00)00095-7","volume":"2","author":"J V\u00edtovec","year":"2000","unstructured":"V\u00edtovec J, \u0160pinar J. First-dose hypotension after angiotensin-converting enzyme (ace) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Eur J Heart Fail. 2000; 2(3):299\u2013304.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"3093_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0014-2999(81)90338-1","volume":"75","author":"WE Burmeister","year":"1981","unstructured":"Burmeister WE, Reynolds RD, Lee RJ. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs. Eur J Pharmacol. 1981; 75(1):7\u201310.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3093_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/clpt.1985.28","volume":"37","author":"RA Reeves","year":"1985","unstructured":"Reeves RA, From GL, Paul W, Leenen FH. Nadolol, propranolol, and thyroid hormones: Evidence for a membrane-stabilizing action of propranolol. Clin Pharmacol Therap. 1985; 37(2):157\u201361.","journal-title":"Clin Pharmacol Therap"},{"issue":"3","key":"3093_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3999\/jscpt.19.573","volume":"19","author":"E UCHIDA","year":"1988","unstructured":"UCHIDA E, OGUCHI K, HISAOKA M, KOBAYASHI S, KAI K, YASUHARA H. Effects of ranitidine, metoclopromide, and anisotropine methylbromide on the availability of cefpodoxime proxetil (cs-807) in japanese healthy subjects. Rinsho yakuri\/Japan J Clin Pharmacol Therap. 1988; 19(3):573\u20139.","journal-title":"Rinsho yakuri\/Japan J Clin Pharmacol Therap"},{"issue":"4","key":"3093_CR64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/10826070601093895","volume":"30","author":"A El-Beqqali","year":"2007","unstructured":"El-Beqqali A, Kussak A, Blomberg L, Abdel-Rehim M. Microextraction in packed syringe\/liquid chromatography\/electrospray tandem mass spectrometry for quantification of acebutolol and metoprolol in human plasma and urine samples. J Liquid Chromatogr Rel Technol. 2007; 30(4):575\u201386.","journal-title":"J Liquid Chromatogr Rel Technol"},{"issue":"3","key":"3093_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1517\/14740338.2012.670633","volume":"11","author":"M Florentin","year":"2012","unstructured":"Florentin M, Elisaf MS. Simvastatin interactions with other drugs. Exp Opin Drug Safety. 2012; 11(3):439\u201344.","journal-title":"Exp Opin Drug Safety"},{"issue":"7","key":"3093_CR66","first-page":"3","volume":"115","author":"G Treyger","year":"2015","unstructured":"Treyger G, Silver SA, Sakharova AA. Pheochromocytoma diagnosis after an abnormal stress test: Case report and review of the literature. J. 2015; 115(7):3.","journal-title":"J"},{"issue":"14","key":"3093_CR67","doi-asserted-by":"publisher","first-page":"i455","DOI":"10.1093\/bioinformatics\/btz331","volume":"35","author":"M Yang","year":"2019","unstructured":"Yang M, Luo H, Li Y, Wang J. Drug repositioning based on bounded nuclear norm regularization. Bioinformatics. 2019; 35(14):i455\u201363. https:\/\/doi.org\/10.1093\/bioinformatics\/btz331. (to be published).","journal-title":"Bioinformatics"},{"issue":"1","key":"3093_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/BDMA.2018.9020001","volume":"1","author":"J Liu","year":"2018","unstructured":"Liu J, Pan Y, Li M, Chen Z, Tang L, Lu C, Wang J. Applications of deep learning to mri images: A survey. Big Data Mining Anal. 2018; 1(1):1\u201318.","journal-title":"Big Data Mining Anal"},{"issue":"6","key":"3093_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12918-018-0624-4","volume":"12","author":"L Liu","year":"2018","unstructured":"Liu L, Yu Y, Fei Z, Li M, Wu F-X, Li H-D, Pan Y, Wang J. An interpretable boosting model to predict side effects of analgesics for osteoarthritis. BMC Syst Biol. 2018; 12(6):105.","journal-title":"BMC Syst Biol"},{"issue":"3","key":"3093_CR70","first-page":"27","volume":"2","author":"C-C Chang","year":"2011","unstructured":"Chang C-C, Lin C-J. Libsvm: a library for support vector machines. ACM Trans Intell Syst Technol (TIST). 2011; 2(3):27.","journal-title":"ACM Trans Intell Syst Technol (TIST)"},{"key":"3093_CR71","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.neucom.2013.08.004","volume":"123","author":"C Lin","year":"2014","unstructured":"Lin C, Chen W, Qiu C, Wu Y, Krishnan S, Zou Q. Libd3c: ensemble classifiers with a clustering and dynamic selection strategy. Neurocomputing. 2014; 123:424\u201335.","journal-title":"Neurocomputing"},{"issue":"7","key":"3093_CR72","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1007\/s10489-017-1063-4","volume":"48","author":"H Wang","year":"2018","unstructured":"Wang H, Wang J, Zhou L. A survival ensemble of extreme learning machine. Appl Intell. 2018; 48(7):1846\u201358.","journal-title":"Appl Intell"},{"key":"3093_CR73","doi-asserted-by":"publisher","unstructured":"Luo H, Wang J, Yan C, Li M, Fangxiang W, Yi P. A novel drug repositioning approach based on collaborative metric learning. IEEE\/ACM Trans Comput Biol Bioinforma. 2019. https:\/\/doi.org\/10.1109\/TCBB.2019.2926453. (to be published).","DOI":"10.1109\/TCBB.2019.2926453"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-3093-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3093-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:09:00Z","timestamp":1695550140000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-3093-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":73,"journal-issue":{"issue":"S15","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3093"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-3093-x","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"31 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}